Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 181

1.

Biodistribution of size-selected lyophilisomes in mice.

van Bracht E, Raavé R, Perevyazko IY, Versteeg EM, Hafmans TG, Schubert US, Oosterwijk E, van Kuppevelt TH, Daamen WF.

Eur J Pharm Biopharm. 2015 Aug;94:141-51. doi: 10.1016/j.ejpb.2015.04.020. Epub 2015 May 5.

PMID:
25953331
2.

Successful combination of sunitinib and girentuximab in two renal cell carcinoma animal models: a rationale for combination treatment of patients with advanced RCC.

Oosterwijk-Wakka JC, de Weijert MC, Franssen GM, Leenders WP, van der Laak JA, Boerman OC, Mulders PF, Oosterwijk E.

Neoplasia. 2015 Feb;17(2):215-24. doi: 10.1016/j.neo.2014.12.011.

3.

Radionuclide and Fluorescence Imaging of Clear Cell Renal Cell Carcinoma Using Dual Labeled Anti-Carbonic Anhydrase IX Antibody G250.

Muselaers CH, Rijpkema M, Bos DL, Langenhuijsen JF, Oyen WJ, Mulders PF, Oosterwijk E, Boerman OC.

J Urol. 2015 Aug;194(2):532-8. doi: 10.1016/j.juro.2015.02.041. Epub 2015 Feb 14.

PMID:
25686542
4.

Urinary cytokines in patients treated with intravesical mitomycin-C with and without hyperthermia.

Arends TJ, Falke J, Lammers RJ, Somford DM, Hendriks JC, de Weijert MC, Arentsen HC, van der Heijden AG, Oosterwijk E, Alfred Witjes J.

World J Urol. 2014 Dec 10. [Epub ahead of print]

PMID:
25491674
5.

Recent advances in ureteral tissue engineering.

de Jonge PK, Simaioforidis V, Geutjes PJ, Oosterwijk E, Feitz WF.

Curr Urol Rep. 2015 Jan;16(1):465. doi: 10.1007/s11934-014-0465-7. Review.

6.

Enhanced cellular uptake of albumin-based lyophilisomes when functionalized with cell-penetrating peptide TAT in HeLa cells.

van Bracht E, Versteegden LR, Stolle S, Verdurmen WP, Woestenenk R, Raavé R, Hafmans T, Oosterwijk E, Brock R, van Kuppevelt TH, Daamen WF.

PLoS One. 2014 Nov 4;9(11):e110813. doi: 10.1371/journal.pone.0110813. eCollection 2014.

7.

Autophagy controls BCG-induced trained immunity and the response to intravesical BCG therapy for bladder cancer.

Buffen K, Oosting M, Quintin J, Ng A, Kleinnijenhuis J, Kumar V, van de Vosse E, Wijmenga C, van Crevel R, Oosterwijk E, Grotenhuis AJ, Vermeulen SH, Kiemeney LA, van de Veerdonk FL, Chamilos G, Xavier RJ, van der Meer JW, Netea MG, Joosten LA.

PLoS Pathog. 2014 Oct 30;10(10):e1004485. doi: 10.1371/journal.ppat.1004485. eCollection 2014 Oct.

8.

Tissue engineering of diseased bladder using a collagen scaffold in a bladder exstrophy model.

Roelofs LA, Kortmann BB, Oosterwijk E, Eggink AJ, Tiemessen DM, Crevels AJ, Wijnen RM, Daamen WF, van Kuppevelt TH, Geutjes PJ, Feitz WF.

BJU Int. 2014 Sep;114(3):447-57.

PMID:
25302355
9.

Identification of potential bladder progenitor cells in the trigone.

Sun W, Wilhelmina Aalders T, Oosterwijk E.

Dev Biol. 2014 Sep 1;393(1):84-92. doi: 10.1016/j.ydbio.2014.06.018. Epub 2014 Jun 30.

PMID:
24992712
10.

Tissue engineering in animal models for urinary diversion: a systematic review.

Sloff M, de Vries R, Geutjes P, IntHout J, Ritskes-Hoitinga M, Oosterwijk E, Feitz W.

PLoS One. 2014 Jun 25;9(6):e98734. doi: 10.1371/journal.pone.0098734. eCollection 2014. Erratum in: PLoS One. 2014;9(8):e105484.

11.

Correlation between in vivo 18F-FDG PET and immunohistochemical markers of glucose uptake and metabolism in pheochromocytoma and paraganglioma.

van Berkel A, Rao JU, Kusters B, Demir T, Visser E, Mensenkamp AR, van der Laak JA, Oosterwijk E, Lenders JW, Sweep FC, Wevers RA, Hermus AR, Langenhuijsen JF, Kunst DP, Pacak K, Gotthardt M, Timmers HJ.

J Nucl Med. 2014 Aug;55(8):1253-9. doi: 10.2967/jnumed.114.137034. Epub 2014 Jun 12.

12.

Optimizing lutetium 177-anti-carbonic anhydrase IX radioimmunotherapy in an intraperitoneal clear cell renal cell carcinoma xenograft model.

Muselaers CH, Oosterwijk E, Bos DL, Oyen WJ, Mulders PF, Boerman OC.

Mol Imaging. 2014;13:1-7.

PMID:
24824962
13.

Tissue engineering of the bladder--reality or myth? A systematic review.

Sloff M, Simaioforidis V, de Vries R, Oosterwijk E, Feitz W.

J Urol. 2014 Oct;192(4):1035-42. doi: 10.1016/j.juro.2014.03.116. Epub 2014 Apr 21. Review.

PMID:
24769032
14.

Optical Imaging of Renal Cell Carcinoma with Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab.

Muselaers CH, Stillebroer AB, Rijpkema M, Franssen GM, Oosterwijk E, Mulders PF, Oyen WJ, Boerman OC.

J Nucl Med. 2014 Jun;55(6):1035-40. doi: 10.2967/jnumed.114.137356. Epub 2014 Apr 21.

15.

Neoadjuvant sorafenib treatment of clear cell renal cell carcinoma and release of circulating tumor fragments.

Kats-Ugurlu G, Oosterwijk E, Muselaers S, Oosterwijk-Wakka J, Hulsbergen-van de Kaa C, de Weijert M, van Krieken H, Desar I, van Herpen C, Maass C, de Waal R, Mulders P, Leenders W.

Neoplasia. 2014 Mar;16(3):221-8. doi: 10.1016/j.neo.2014.03.007. Epub 2014 Apr 13.

16.

Preclinical imaging in bone tissue engineering.

Ventura M, Boerman OC, de Korte C, Rijpkema M, Heerschap A, Oosterwijk E, Jansen JA, Walboomers XF.

Tissue Eng Part B Rev. 2014 Dec;20(6):578-95. doi: 10.1089/ten.TEB.2013.0635. Epub 2014 May 29. Review.

PMID:
24720381
17.

In vivo magnetic resonance imaging of type I collagen scaffold in rat: improving visualization of bladder and subcutaneous implants.

Sun Y, Geutjes P, Oosterwijk E, Heerschap A.

Tissue Eng Part C Methods. 2014 Dec;20(12):964-71. doi: 10.1089/ten.TEC.2014.0046. Epub 2014 Apr 24.

PMID:
24625324
18.

Targeting ion transport in cancer.

Oosterwijk E, Gillies RJ.

Philos Trans R Soc Lond B Biol Sci. 2014 Feb 3;369(1638):20130107. doi: 10.1098/rstb.2013.0107. Print 2014 Mar 19.

19.

Specific targeting of tumor cells by lyophilisomes functionalized with antibodies.

van Bracht E, Stolle S, Hafmans TG, Boerman OC, Oosterwijk E, van Kuppevelt TH, Daamen WF.

Eur J Pharm Biopharm. 2014 May;87(1):80-9. doi: 10.1016/j.ejpb.2014.01.005. Epub 2014 Jan 23.

PMID:
24463217
20.

Tyrosine kinase inhibitor sorafenib decreases 111In-girentuximab uptake in patients with clear cell renal cell carcinoma.

Muselaers CH, Stillebroer AB, Desar IM, Boers-Sonderen MJ, van Herpen CM, de Weijert MC, Langenhuijsen JF, Oosterwijk E, Leenders WP, Boerman OC, Mulders PF, Oyen WJ.

J Nucl Med. 2014 Feb;55(2):242-7. doi: 10.2967/jnumed.113.131110. Epub 2014 Jan 6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk